MedTrace Logo

GRAM NEGATIVES STUDY

NCT07749508 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2026-08-06

No results posted yet for this study

Summary

This is a prospective, observational, multicenter study whose main objective is to develop a predictive model of mortality in critically ill patients colonized by multidrug-resistant Gram-negative bacteria (MDR-GNB).

Secondary objectives include: determining the characteristics of patients colonized by MRGB who require admission or acquire colonization during their stay in an intensive care unit (ICU); studying the infectious complications they develop, their etiology, clinical impact, and prognosis.

Conditions

  • Multi-resistant Gram-negative Bacteria Cause Infection

Interventions

DRUG

Standard of care therapy

This is an observational study. Patients receive standard of care therapy as part of routine clinical practice according to the physician's discretion. No experimental intervention is assigned by the protocol.

Sponsors & Collaborators

  • Fundacion SEIMC-GESIDA

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-02
Primary Completion
2027-05-31
Completion
2027-05-31
FDA Drug
Yes

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07749508 on ClinicalTrials.gov